National Health Investors (NHI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Werte in diesem Artikel
National Health Investors (NHI) reported $85.75 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 7.9%. EPS of $1.13 for the same period compares to $0.74 a year ago.The reported revenue represents a surprise of +2.52% over the Zacks Consensus Estimate of $83.64 million. With the consensus EPS estimate being $1.10, the EPS surprise was +2.73%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how National Health Investors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Rental income: $65.78 million versus the two-analyst average estimate of $62.06 million. The reported number represents a year-over-year change of +8.3%. Revenues- Interest income and other: $5.97 million versus $5.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +3% change. Revenues- Resident fees and services: $14 million versus the two-analyst average estimate of $13.88 million. The reported number represents a year-over-year change of +8.1%. Earnings per common share- Diluted: $0.95 versus $0.71 estimated by three analysts on average. View all Key Company Metrics for National Health Investors here>>>Shares of National Health Investors have returned -0.2% over the past month versus the Zacks S&P 500 composite's -1.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report National Health Investors, Inc. (NHI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf National Health Investors
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf National Health Investors
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu National Health Investors IncShs
Analysen zu National Health Investors IncShs
Datum | Rating | Analyst | |
---|---|---|---|
22.02.2019 | National Health Investors Underperform | BMO Capital Markets | |
09.11.2015 | National Health Investors Buy | Stifel, Nicolaus & Co., Inc. | |
08.05.2015 | National Health Investors Neutral | Mizuho | |
10.04.2015 | National Health Investors Outperform | BMO Capital Markets | |
03.03.2015 | National Health Investors Neutral | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
09.11.2015 | National Health Investors Buy | Stifel, Nicolaus & Co., Inc. | |
10.04.2015 | National Health Investors Outperform | BMO Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
08.05.2015 | National Health Investors Neutral | Mizuho | |
03.03.2015 | National Health Investors Neutral | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
22.02.2019 | National Health Investors Underperform | BMO Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für National Health Investors IncShs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen